Skip to main content

Research Repository

Advanced Search

The role of mesenchymal cells in cholangiocarcinoma

Sueca-Comes, Mireia; Cristina Rusu, Elena; Ashworth, Jennifer C.; Collier, Pamela; Probert, Catherine; Ritchie, Alison; Meakin, Marian; P. Mongan, Nigel; Egbuniwe, Isioma U.; Andersen, Jesper Bøje; Bates, David O.; Grabowska, Anna M.

The role of mesenchymal cells in cholangiocarcinoma Thumbnail


Authors

Mireia Sueca-Comes

Elena Cristina Rusu

Pamela Collier

Catherine Probert

Alison Ritchie

Marian Meakin

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Associate Pro-Vice Chancellorglobal Engagement

Isioma U. Egbuniwe

Jesper Bøje Andersen

DAVID BATES David.Bates@nottingham.ac.uk
Professor of Oncology

Anna M. Grabowska



Abstract

The tumour microenvironment (TME) significantly influences tumour formation and progression through dynamic interactions. Cholangiocarcinoma (CCA), a highly desmoplastic tumour, lacks early diagnostic biomarkers and has limited effective treatments due to an incomplete understanding of its molecular pathogenesis. Investigating the TME's role in CCA progression could lead to better therapies.

RNA sequencing was performed on seven CCA PDXs and their corresponding patient samples. Differential expression analysis was conducted, and Qiagen Ingenuity Pathway Analysis (IPA) was used to predict dysregulated pathways and upstream regulators. PDX and cell line-derived spheroids, with and without immortalised mesenchymal stem cells, were grown and analysed for morphology, growth, and viability. Histological analysis confirmed biliary phenotypes. RNA sequencing indicated upregulation of ECM-receptor interaction and PI3K-Akt pathways in the presence of MSCs, with several genes linked to poor survival. MSCs restored the activity of inhibited cancer-associated kinases (ICAKs).

This study shows that adding MSCs to CCA spheroid models restores key paracrine signalling pathways lost in PDXs, enhancing tumour growth and viability. These findings highlight the importance of including stromal components in cancer models to improve pre-clinical studies.

Citation

Sueca-Comes, M., Cristina Rusu, E., Ashworth, J. C., Collier, P., Probert, C., Ritchie, A., Meakin, M., P. Mongan, N., Egbuniwe, I. U., Andersen, J. B., Bates, D. O., & Grabowska, A. M. (2024). The role of mesenchymal cells in cholangiocarcinoma. Disease Models and Mechanisms, https://doi.org/10.1242/dmm.050716

Journal Article Type Article
Acceptance Date Oct 17, 2024
Online Publication Date Nov 4, 2024
Publication Date Nov 4, 2024
Deposit Date Nov 15, 2024
Publicly Available Date Nov 19, 2024
Journal Disease Models and Mechanisms
Print ISSN 1754-8403
Electronic ISSN 1754-8411
Publisher Company of Biologists
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1242/dmm.050716
Public URL https://nottingham-repository.worktribe.com/output/41678898
Publisher URL https://journals.biologists.com/dmm/article/doi/10.1242/dmm.050716/362583/The-role-of-mesenchymal-cells-in

Files





You might also like



Downloadable Citations